A case of acute interstitial pneumonia which developed during the interferon and ribavirin treatment for chronic hepatitis C Source: Eur Respir J 2005; 26: Suppl. 49, 84s Year: 2005
Fatal interstitial pneumonitis in a patient treated with pegylated interferon alpha-2b and ribavirin for hepatitis C infection Source: Eur Respir J 2003; 22: Suppl. 45, 44s Year: 2003
Sarcoidosis associated with interferon-α therapy for chronic hepatitis C Source: Eur Respir J 2006; 28: Suppl. 50, 541s Year: 2006
Fulminant hepatitis during antituberculosis chemotherapy: five case reports Source: Eur Respir J 2005; 26: Suppl. 49, 645s Year: 2005
Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: 496-504 Year: 2006
The role of hepatitis C virus infections in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 333s Year: 2005
Interstitial lung involvement in patients with chronic HCV hepatitis Source: Eur Respir J 2006; 28: Suppl. 50, 744s Year: 2006
Combination treatment with nintedanib and prednisolone for patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018
The impact of bedaquiline and delamanid containing regimens on liver function in patients multi-infected with pulmonary DR-TB, HIV and viral hepatitis Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019
Features the effectiveness of the treatment of moxifloxacin in patients with co-infections tuberculosis/HIV and hepatitis B,and/or C Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020
Impact of direct-acting antiviral (DAA) treatment for hepatitis C on pulmonary hemodynamics Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension Year: 2020
Treatment of Idiopathic pulmonary fibrosis with interferon beta - our experience in seven patients Source: Eur Respir J 2003; 22: Suppl. 45, 44s Year: 2003
Successful treatment of severe respiratory papillomatosis with intravenous cidofovir and interferon α-2b Source: Eur Respir J 2002; 20: Suppl. 38, 157s Year: 2002
Influence of viral hepatitis and anti-TB drugs on hepatocyte disfunction in patients with MDR/XDR tuberculosis Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021
Prevention of drug-induced liver injury in patients with pulmonary tuberculosis and chronic hepatitis C Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019
Severe hepatitis associated with sitaxentan and response to glucocorticoid therapy Source: Eur Respir J 2009; 33: 1518-1519 Year: 2009
Clinical-evolutive aspects of pulmonary tuberculosis at patients with chronic hepatitis Source: Annual Congress 2007 - Tuberculosis Year: 2007
Colchicine, prednisone versus no therapy in idiopathic pulmonary fibosis Source: Eur Respir J 2006; 28: Suppl. 50, 744s Year: 2006
Clinical and morphological outcomes of pulmonary tuberculosis concurrent with chronic hepatitis Source: Eur Respir J 2006; 28: Suppl. 50, 13s Year: 2006
Results of treatment of patients with pulmonary tuberculosis combined with HIV infection and hepatitis Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018